These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 24718088)

  • 1. Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: clinical features and susceptibilities of the isolates.
    Lee MR; Ko JC; Liang SK; Lee SW; Yen DH; Hsueh PR
    Int J Antimicrob Agents; 2014 May; 43(5):438-41. PubMed ID: 24718088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
    Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
    Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
    Yoshida S; Tsuyuguchi K; Suzuki K; Tomita M; Okada M; Hayashi S; Iwamoto T; Saito H
    Int J Antimicrob Agents; 2013 Sep; 42(3):226-31. PubMed ID: 23850022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapulmonary infections caused by a dominant strain of Mycobacterium massiliense (Mycobacterium abscessus subspecies bolletii).
    Cheng A; Liu YC; Chen ML; Hung CC; Tsai YT; Sheng WH; Liao CH; Hsueh PR; Chen YC; Chang SC
    Clin Microbiol Infect; 2013 Oct; 19(10):E473-82. PubMed ID: 23718188
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex.
    Rubio M; March F; Garrigó M; Moreno C; Español M; Coll P
    PLoS One; 2015; 10(10):e0140166. PubMed ID: 26448181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
    J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia.
    Chua KY; Bustamante A; Jelfs P; Chen SC; Sintchenko V
    Pathology; 2015 Dec; 47(7):678-82. PubMed ID: 26517625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates.
    Nie W; Duan H; Huang H; Lu Y; Chu N
    Biomed Res Int; 2015; 2015():506598. PubMed ID: 26146620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
    Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
    Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L
    Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
    Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
    Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.